RNA Extraction Using TRIzol Reagent: Protocol, Troubleshooting, and Best Practices

TRIzol-based RNA extraction is a single-step, guanidinium thiocyanate-phenol-chloroform method that simultaneously isolates total RNA, DNA, and proteins from a single biological sample. This protocol is particularly useful for cultured mammalian cells and bacterial pellets when high-quality, intact RNA is required for downstream applications such as reverse transcription quantitative PCR (RT-qPCR), RNA sequencing, or RNA immunoprecipitation (RIP) assays [2]. The method exploits the differential partitioning of nucleic acids and proteins between aqueous and organic phases under acidic conditions, yielding RNA that is free of genomic DNA contamination when performed correctly. This article provides a detailed, step-by-step protocol optimized for BSL-1 routine laboratory work, with a dedicated troubleshooting section addressing low yield, degradation, and phase separation issues. It is designed for students, laboratory technicians, and early-career researchers working with cultured cells or bacterial pellets.

At a Glance

Scientific Principle

TRIzol reagent contains a monophasic solution of guanidinium thiocyanate, phenol, and glycerol. Guanidinium thiocyanate is a chaotropic agent that denatures proteins, including RNases, and disrupts cellular and nuclear membranes. Under acidic conditions (pH ~4.0), phenol partitions RNA into the aqueous phase while DNA and proteins remain in the interphase and organic phase, respectively. This differential partitioning occurs because RNA, with its additional 2′-hydroxyl group, is more acidic than DNA and remains protonated and soluble in the aqueous phase at low pH. After phase separation by chloroform addition and centrifugation, RNA is precipitated from the aqueous phase using isopropanol, washed with ethanol, and resuspended in RNase-free water or buffer.

The method's efficiency depends critically on maintaining acidic pH throughout the initial homogenization and phase separation steps. If the pH becomes neutral or alkaline, DNA will partition into the aqueous phase, causing genomic DNA contamination. The protocol also relies on complete homogenization to ensure uniform cell lysis and RNase inactivation, which is essential for preserving RNA integrity [1].

Materials and Instrumentation

Reagents

• TRIzol reagent (commercially available from multiple suppliers; store at 4°C protected from light)
• Chloroform (molecular biology grade, ≥99%)
• Isopropanol (molecular biology grade, ≥99%)
• Ethanol (molecular biology grade, 75% v/v in RNase-free water, prepared fresh)
• RNase-free water (DEPC-treated or commercially certified)
• Optional: Glycogen (20 mg/mL, molecular biology grade) for low-yield samples
• Optional: DNase I (RNase-free) for rigorous genomic DNA removal

Consumables

• RNase-free microcentrifuge tubes (1.5 mL or 2.0 mL)
• RNase-free pipette tips with aerosol barriers
• Sterile, RNase-free serological pipettes (for larger volumes)
• Ice bucket

Equipment

• Refrigerated microcentrifuge (capable of 12,000 × g at 4°C)
• Vortex mixer
• Pipettes (P10, P100, P200, P1000) calibrated for accuracy
• Nanodrop spectrophotometer or equivalent for purity assessment
• Agarose gel electrophoresis apparatus (for integrity check)
• Biosafety cabinet (for bacterial pellet processing)
• -80°C freezer for long-term RNA storage

Reagent Preparation Notes

Prepare 75% ethanol fresh on the day of extraction using RNase-free water. Pre-chill isopropanol and 75% ethanol to -20°C for 30 minutes before use to improve RNA precipitation efficiency. All glassware should be baked at 180°C for 4 hours or treated with RNase Away solution. Plasticware should be certified RNase-free. The use of aerosol-barrier tips is mandatory to prevent cross-contamination and RNase introduction [5].

Controls

Including appropriate controls is essential for interpreting RNA extraction quality and troubleshooting downstream applications.

• Positive control: A sample of known high-quality RNA (e.g., commercially available human reference RNA) processed in parallel to verify reagent integrity and technique.
• Negative control (no-cell control): Process an empty tube containing only TRIzol through the entire protocol to detect reagent contamination with RNases or nucleic acids.
• DNase-treated control: For applications requiring absolute genomic DNA removal (e.g., RT-qPCR for intron-spanning assays), include a sample treated with RNase-free DNase I post-extraction.
• Spike-in control: For quantitative applications, add a known amount of exogenous RNA (e.g., synthetic luciferase mRNA) to the lysis buffer to monitor recovery efficiency.

Conceptual Workflow

Step 1: Sample Preparation and Homogenization

For cultured mammalian cells (adherent or suspension):

1. Harvest cells by trypsinization (adherent) or centrifugation (suspension). Count cells using a hemocytometer.
2. Wash cell pellet once with ice-cold 1× PBS to remove serum and media components that may interfere with extraction.
3. Centrifuge at 300 × g for 5 minutes at 4°C. Remove supernatant completely.
4. Add 1 mL TRIzol per 5–10 × 10⁶ cells. For smaller pellets (1 × 10⁶ cells), use 0.5 mL TRIzol.
5. Homogenize by pipetting up and down 10–15 times until the lysate is no longer viscous. Alternatively, vortex for 15 seconds.

For bacterial pellets (BSL-1 strains only):

1. Harvest bacterial culture by centrifugation at 5,000 × g for 10 minutes at 4°C.
2. Wash pellet with ice-cold 1× PBS. Centrifuge again.
3. Resuspend pellet in 1 mL TRIzol per 10⁹ bacterial cells.
4. Homogenize by vortexing for 30 seconds, then pass through a 21-gauge needle 5–10 times to shear genomic DNA and reduce viscosity.

Critical decision point: Incomplete homogenization leads to low RNA yield and potential degradation. For bacterial pellets, mechanical shearing is often necessary due to the rigid cell wall. For mammalian cells, excessive vortexing after lysis may shear RNA; gentle pipetting is preferred [1].

Step 2: Phase Separation

1. Incubate homogenized samples at room temperature (15–25°C) for 5 minutes to allow complete dissociation of nucleoprotein complexes.
2. Add 0.2 mL chloroform per 1 mL TRIzol used. Cap tubes securely.
3. Shake tubes vigorously by hand for 15 seconds. Do not vortex, as this may shear RNA.
4. Incubate at room temperature for 2–3 minutes.
5. Centrifuge at 12,000 × g for 15 minutes at 4°C.

After centrifugation, three distinct phases should be visible:

• Upper aqueous phase (clear, colorless): Contains RNA
• Interphase (white, flocculent): Contains DNA
• Lower organic phase (pink/red): Contains proteins and lipids

Critical decision point: The volume of the aqueous phase is approximately 50–60% of the total volume. Carefully aspirate the aqueous phase without disturbing the interphase. If the interphase is disturbed, recentrifuge for 5 minutes. For low-yield samples, leave a small volume (10–20 µL) of aqueous phase behind rather than risk DNA contamination.

Step 3: RNA Precipitation

1. Transfer the aqueous phase to a fresh RNase-free tube.
2. Add 0.5 mL isopropanol per 1 mL TRIzol used. For low-yield samples (<5 µg expected), add 1 µL glycogen as a co-precipitant.
3. Invert tubes gently 5–6 times to mix. Do not vortex.
4. Incubate at room temperature for 10 minutes. Longer incubation (up to 30 minutes) at -20°C may improve yield for dilute samples but risks salt precipitation.
5. Centrifuge at 12,000 × g for 10 minutes at 4°C. The RNA pellet should be visible as a white or translucent pellet at the bottom of the tube.

Critical decision point: Isopropanol precipitation is more efficient than ethanol for RNA recovery, especially for small RNA species. However, isopropanol also precipitates salts more readily. If the pellet appears excessively white or crystalline, consider an additional 75% ethanol wash step.

Step 4: RNA Wash

1. Carefully remove supernatant without disturbing the pellet. Use a P200 pipette for the final removal.
2. Add 1 mL of 75% ethanol (pre-chilled to -20°C) per 1 mL TRIzol used.
3. Vortex briefly (5 seconds) to dislodge the pellet and ensure thorough washing.
4. Centrifuge at 7,500 × g for 5 minutes at 4°C.
5. Remove supernatant completely. A brief second spin (30 seconds) at 7,500 × g may help collect residual ethanol.
6. Air-dry the pellet for 5–10 minutes at room temperature. Do not overdry, as this reduces RNA solubility.

Critical decision point: Overdrying (beyond 15 minutes) makes the RNA pellet difficult to resuspend and may lead to degradation. The pellet should appear slightly translucent, not completely dry and cracked.

Step 5: RNA Resuspension

1. Resuspend the pellet in 20–50 µL RNase-free water or TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 7.5).
2. Pipette gently up and down 5–10 times. If the pellet is difficult to dissolve, incubate at 55–60°C for 5 minutes, then place on ice.
3. Store RNA at -80°C for long-term storage. For short-term use (1–2 days), store at -20°C.

Critical decision point: TE buffer is preferred for long-term storage as EDTA chelates Mg²⁺ ions required by RNases. However, EDTA can inhibit downstream enzymatic reactions (e.g., reverse transcription) if present at >0.5 mM final concentration. For immediate use, RNase-free water is acceptable.

Quality Checks

Purity Assessment by Spectrophotometry

Measure absorbance at 260 nm, 280 nm, and 230 nm using a Nanodrop or similar microvolume spectrophotometer.

• A₂₆₀/A₂₈₀ ratio: 1.8–2.1 indicates pure RNA. Values <1.8 suggest protein or phenol contamination. Values >2.1 may indicate RNA degradation or residual guanidinium.
• A₂₆₀/A₂₃₀ ratio: >1.8 indicates minimal guanidinium, phenol, or carbohydrate contamination. Values <1.5 suggest significant contamination that may inhibit downstream reactions.

Integrity Assessment by Gel Electrophoresis

Run 1–2 µg RNA on a 1.2% agarose gel in 1× TAE buffer containing 0.5 µg/mL ethidium bromide. Use a denaturing gel (with formaldehyde) for more accurate assessment.

• Intact RNA: Two distinct bands corresponding to 28S rRNA (~4.7 kb) and 18S rRNA (~1.9 kb) with a 28S:18S intensity ratio of approximately 2:1.
• Partially degraded RNA: Smearing below the 18S band, reduced 28S:18S ratio.
• Severely degraded RNA: Complete smear with no distinct bands.

Quantitative Assessment

Calculate RNA concentration using the Beer-Lambert law: Concentration (µg/mL) = A₂₆₀ × 40 (for RNA). For example, an A₂₆₀ reading of 0.5 corresponds to 20 µg/mL RNA.

Optional: DNase Treatment

For applications sensitive to genomic DNA contamination, treat 10–20 µg RNA with 1–2 U RNase-free DNase I in 1× DNase buffer for 30 minutes at 37°C. Purify by phenol-chloroform extraction or column-based cleanup.

Result Interpretation

Expected Yields

Interpreting Purity Ratios

• A₂₆₀/A₂₈₀ = 1.8–2.1: Acceptable for most downstream applications.
• A₂₆₀/A₂₈₀ < 1.8: Possible protein contamination. Re-extract with phenol:chloroform:isoamyl alcohol (25:24:1) pH 4.5.
• A₂₆₀/A₂₃₀ < 1.5: Guanidinium or phenol carryover. Perform an additional 75% ethanol wash.
• A₂₆₀/A₂₃₀ > 2.2: Possible RNA degradation; check integrity by gel.

Interpreting Integrity

• RIN > 7.0: Suitable for RNA-seq and most applications.
• RIN 5.0–7.0: Acceptable for RT-qPCR with short amplicons (<200 bp).
• RIN < 5.0: RNA is degraded; re-extract from fresh sample.

Troubleshooting

Limitations

• Not suitable for very small samples (<10⁴ cells): Column-based methods or carrier RNA are more appropriate for trace amounts.
• Cannot separate small RNAs (<200 nt) efficiently: For miRNA or siRNA recovery, use specialized TRIzol-based protocols with ethanol precipitation modifications.
• Phenol carryover risk: Incomplete removal of the aqueous phase or improper phase separation can introduce phenol, which inhibits downstream enzymes.
• Not compatible with some downstream applications: Residual guanidinium can inhibit reverse transcriptase; additional purification may be required.
• Chemical hazard: Phenol and chloroform are toxic and must be handled in a fume hood with appropriate PPE.
• Not for clinical diagnostics: This protocol is for research use only; clinical RNA extraction requires validated, FDA-approved kits.
• Bacterial RNA extraction challenges: Gram-positive bacteria require additional mechanical disruption (e.g., bead beating) for efficient lysis, which is not covered in this protocol.

Documentation

Maintain a laboratory notebook with the following information for each extraction:

• Sample metadata: Cell type, passage number, culture conditions, bacterial strain, growth phase
• Cell count: Number of cells or bacterial CFU used
• TRIzol volume: Volume used per sample
• Homogenization method: Pipetting, vortexing, needle shearing
• Incubation times: Room temperature incubation after homogenization, after chloroform addition, after isopropanol addition
• Centrifugation conditions: Speed, time, temperature
• Resuspension volume: Volume of RNase-free water or TE buffer
• Yield and purity: A₂₆₀, A₂₈₀, A₂₃₀, concentration, A₂₆₀/A₂₈₀, A₂₆₀/A₂₃₀
• Integrity assessment: Gel image or RIN value
• Storage conditions: Temperature and date of storage
• Downstream application: RT-qPCR, RNA-seq, etc.

Standardize documentation using a template to ensure reproducibility across experiments [5].

Biosafety Considerations

This protocol is designed for BSL-1 routine laboratory work. All microbiological procedures must follow the principles outlined in the Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition [3]. Key safety measures include:

• Chemical hazards: TRIzol contains phenol (corrosive, toxic) and guanidinium thiocyanate (irritant). Chloroform is a suspected carcinogen and hepatotoxin. Work in a chemical fume hood for all steps involving these reagents. Wear nitrile gloves, lab coat, and safety goggles.
• Biological hazards: For BSL-1 organisms (e.g., non-pathogenic E. coli K-12 strains), standard aseptic technique is sufficient. Do not use this protocol for pathogenic bacteria, clinical specimens, or select agents.
• Waste disposal: Collect all TRIzol-containing waste (aqueous and organic phases) in designated hazardous waste containers. Do not pour down the drain. Follow institutional guidelines for chemical waste disposal.
• Recombinant nucleic acids: If working with cells containing recombinant or synthetic nucleic acid molecules, follow the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules [4]. This may require Institutional Biosafety Committee (IBC) approval.
• RNase control: While not a biosafety issue, RNase contamination is a major experimental concern. Dedicate a separate work area for RNA work, use RNase-free consumables, and clean surfaces with RNase decontamination solutions.

Frequently Asked Questions

1. Can I use TRIzol for RNA extraction from bacterial pellets without additional mechanical disruption?

For Gram-negative bacteria (e.g., E. coli), TRIzol alone with vortexing and pipetting is often sufficient for efficient lysis. However, for Gram-positive bacteria (e.g., Staphylococcus aureus), the thick peptidoglycan layer requires mechanical disruption such as bead beating or enzymatic treatment (e.g., lysozyme) prior to TRIzol addition. Without this step, yields will be significantly reduced. This protocol is limited to BSL-1 bacterial strains; for Gram-positive BSL-1 strains, include a 30-minute lysozyme treatment (1 mg/mL in TE buffer, pH 8.0) at 37°C before adding TRIzol.

2. Why is my A₂₆₀/A₂₈₀ ratio consistently below 1.8 even though my RNA appears intact on a gel?

A low A₂₆₀/A₂₈₀ ratio typically indicates protein or phenol contamination. If the gel shows intact RNA, phenol carryover is the more likely cause. This often occurs when the aqueous phase is collected too close to the interphase. To resolve this, perform a second chloroform extraction: add an equal volume of chloroform to the recovered aqueous phase, mix, centrifuge, and collect the new aqueous phase before proceeding with isopropanol precipitation. Alternatively, use a commercial RNA cleanup column after the TRIzol extraction.

3. Can I store RNA in TRIzol at -80°C for later extraction?

Yes, homogenized samples in TRIzol can be stored at -80°C for up to 1 month without significant RNA degradation. However, freeze-thaw cycles should be avoided. For long-term storage, it is better to precipitate the RNA and store it in ethanol at -80°C. To store in TRIzol, ensure the sample is completely homogenized, then transfer to a -80°C freezer. When ready to extract, thaw the sample on ice, proceed with phase separation, and follow the standard protocol.

4. How can I improve RNA yield from low-cell-number samples (<10⁵ cells)?

For very small samples, add 1 µL of glycogen (20 mg/mL) as a co-precipitant during the isopropanol precipitation step. Glycogen forms a visible pellet and improves RNA recovery without interfering with downstream applications. Additionally, reduce the TRIzol volume to 0.5 mL and use 0.25 mL chloroform. Centrifuge at maximum speed (20,000 × g) for 20 minutes during precipitation. Consider using a carrier RNA (e.g., linear acrylamide) if glycogen is not compatible with your downstream assay.

References and Further Reading

1. Executing cell-specific cross-linking immunoprecipitation and sequencing (seCLIP) in C. elegans – Blazie SM, Jin Y. (2023). This protocol provides detailed steps for RNA isolation from C. elegans, including TRIzol-based extraction and quality control measures for RNA integrity assessment. PubMed

2. Protocol for evaluating RNA-protein associations in mammalian cells with RIP-seq and RIP-qPCR – Trotman JB, Li S, Eberhard QE, Zhang Z, Calabrese JM. (2026). This protocol describes RNA immunoprecipitation methods that rely on high-quality RNA extracted using TRIzol, including best practices for RNA handling and quality assessment. PubMed

3. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition – CDC and NIH (2020). Authoritative guidelines for laboratory biosafety, including chemical hazard management and waste disposal protocols relevant to TRIzol extraction. CDC

4. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules – National Institutes of Health. Institutional framework for biosafety oversight when working with recombinant organisms or nucleic acids. NIH

5. NCBI Bookshelf: Molecular Biology and Laboratory Methods – National Center for Biotechnology Information. A searchable collection of molecular biology protocols and best practices for RNA extraction and handling. NCBI

Related Articles

• RNA Extraction from Plant Tissues: Methods and Troubleshooting
• RNA Storage and Stability: Best Practices for Preserving Integrity
• RNA Extraction from FFPE Tissues: Challenges and Protocols
• RNA Extraction from Blood: Protocols for Total RNA from Whole Blood
• RNA Extraction from Bacteria: Protocols for Total RNA Isolation
• Preventing RNase Contamination in RNA Work: Lab Practices and Tips